Trial Details
COMPLETEDBasic Information
| Clinical ID | c441 |
|---|---|
| Identifier | NCT00829595 |
| Trial Title | Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease|Crohn Disease|Ulcerative Colitis |
| Interventions | BIOLOGICAL: 23-valent polysaccharide pneumococcal vaccine (Pneumovax TM) |
Participant Information
| Sponsor | Cedars-Sinai Medical Center |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2025-05-05 |
|---|---|
| Primary Completion Date | 2025-12-07 |
| Completion Date | 2025-12-07 |